Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has recently been proposed to replace non-alcoholic fatty liver disease and focus on patients with progressive disease due to the presence of metabolic dysfunction. However, it is unclear whether the new definition actually...

Descripción completa

Detalles Bibliográficos
Autores principales: Semmler, Georg, Balcar, Lorenz, Wernly, Sarah, Völkerer, Andreas, Semmler, Lorenz, Hauptmann, Laurenz, Wernly, Bernhard, Aigner, Elmar, Niederseer, David, Datz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570507/
https://www.ncbi.nlm.nih.gov/pubmed/37842290
http://dx.doi.org/10.3389/fendo.2023.1244405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570507/
https://www.ncbi.nlm.nih.gov/pubmed/37842290
http://dx.doi.org/10.3389/fendo.2023.1244405

Ejemplares similares